Literature DB >> 24632605

Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis.

Q Wang1, B Shen1, L Chen1, P Zheng1, H Feng1, Q Hao1, X Liu1, L Liu1, S Xu1, J Chen2, J Teng1.   

Abstract

Extracellular proteins are vital for cell activities, such as cell migration. Calumenin is highly conserved among eukaryotes, but its functions are largely unclear. Here, we identify extracellular calumenin as a suppressor of cell migration and tumor metastasis. Calumenin binds to and stabilizes fibulin-1, leading to inactivation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling. We further identify the minimal functional domain of calumenin (amino acids 74-138 and 214-280). Depletion of calumenin induces fibulin-1- and phospho-ERK1/2 (pERK1/2)-dependent promotion of cell migration. Consistently, in hepatocellular and pancreatic carcinoma, both calumenin and fibulin-1 are downregulated. Furthermore, we show that matrix metalloproteinase-13 (MMP-13) proteolyzes fibulin-1 and that calumenin protects fibulin-1 from cleavage by MMP-13. Calumenin, together with fibulin-1, also interacts with fibronectin and depends on both syndecan-4 and α5β1-integrin to suppress ERK1/2 signaling and inhibit cell migration. Thus, extracellular calumenin regulates fibulin-1 to have crucial roles in ERK1/2 signaling and cell migration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24632605     DOI: 10.1038/onc.2014.52

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases.

Authors:  Gang Liu; Marion A Cooley; Andrew G Jarnicki; Alan C-Y Hsu; Prema M Nair; Tatt Jhong Haw; Michael Fricker; Shaan L Gellatly; Richard Y Kim; Mark D Inman; Gavin Tjin; Peter A B Wark; Marjorie M Walker; Jay C Horvat; Brian G Oliver; W Scott Argraves; Darryl A Knight; Janette K Burgess; Philip M Hansbro
Journal:  JCI Insight       Date:  2016-06-16

2.  Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies.

Authors:  Yasuyuki Matsumoto; Matthew R Kudelka; Melinda S Hanes; Sylvain Lehoux; Sucharita Dutta; Mark B Jones; Kathryn A Stackhouse; Gabrielle E Cervoni; Jamie Heimburg-Molinaro; David F Smith; Tongzhong Ju; Elliot L Chaikof; Richard D Cummings
Journal:  Glycobiology       Date:  2020-04-20       Impact factor: 4.313

3.  Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis.

Authors:  Gang Liu; Marion A Cooley; Andrew G Jarnicki; Theo Borghuis; Prema M Nair; Gavin Tjin; Alan C Hsu; Tatt Jhong Haw; Michael Fricker; Celeste L Harrison; Bernadette Jones; Nicole G Hansbro; Peter A Wark; Jay C Horvat; W Scott Argraves; Brian G Oliver; Darryl A Knight; Janette K Burgess; Philip M Hansbro
Journal:  JCI Insight       Date:  2019-07-25

4.  Creatine phosphate disodium salt protects against Dox-induced cardiotoxicity by increasing calumenin.

Authors:  Yu Wang; Ying Sun; Xin Guo; Yao Fu; Jie Long; Cheng-Xi Wei; Ming Zhao
Journal:  Med Mol Morphol       Date:  2017-12-27       Impact factor: 2.309

5.  ADAM8 localizes to extravillous trophoblasts within the maternal-fetal interface and potentiates trophoblast cell line migration through a β1 integrin-mediated mechanism.

Authors:  H T Le; J Atif; D L Mara; B Castellana; J Treissman; J Baltayeva; A G Beristain
Journal:  Mol Hum Reprod       Date:  2018-10-01       Impact factor: 4.025

6.  Calumenin knockdown, by intronic artificial microRNA, to improve expression efficiency of the recombinant human coagulation factor IX.

Authors:  Javad Parnian; Maryam Hoseindokht; Zahra Khademi; Maedeh Moosavi; Zahra Soheila Soheili; Shahram Samie; Alireza Zomorodipour
Journal:  Biotechnol Lett       Date:  2022-04-12       Impact factor: 2.461

7.  Integrated Analysis of the ceRNA Network and M-7474 Function in Testosterone-Mediated Fat Deposition in Pigs.

Authors:  Ximing Liu; Ying Bai; Ran Cui; Shuaihan He; Yao Ling; Changxin Wu; Meiying Fang
Journal:  Genes (Basel)       Date:  2022-04-10       Impact factor: 4.141

Review 8.  Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review.

Authors:  Mehdi Hedayati; Raziyeh Abooshahab; S Adeleh Razavi; Pouya Salehipour; Kazem Ahmadikia; Seti Boroomand
Journal:  Mol Biol Rep       Date:  2020-10-26       Impact factor: 2.316

9.  Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin.

Authors:  Gry Aune Westergaard Hansen; Maja Ludvigsen; Christian Jacobsen; Claudia Cangemi; Lars Melholt Rasmussen; Henrik Vorum; Bent Honoré
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

10.  Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.

Authors:  Joshua B N Dawkins; Jun Wang; Eleni Maniati; James A Heward; Lola Koniali; Hemant M Kocher; Sarah A Martin; Claude Chelala; Frances R Balkwill; Jude Fitzgibbon; Richard P Grose
Journal:  Cancer Res       Date:  2016-06-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.